Global Adoptive Cell Transfer Therapy Market Growth (Status and Outlook) 2021-2026

Global Adoptive Cell Transfer Therapy Market Growth (Status and Outlook) 2021-2026

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Adoptive Cell Transfer Therapy Market Size 2016-2026
2.1.2 Adoptive Cell Transfer Therapy Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Adoptive Cell Transfer Therapy Segment by Type
2.2.1 NK
2.2.2 NK
2.2.3 DC
2.2.4 CIK
2.2.5 CTL
2.2.6 TIL
2.2.7 TCR-T
2.2.8 CAR-T
2.3 Adoptive Cell Transfer Therapy Market Size by Type
2.3.1 Global Adoptive Cell Transfer Therapy Market Size CAGR by Type
2.3.2 Global Adoptive Cell Transfer Therapy Market Size Market Share by Type (2016-2021)
2.4 Adoptive Cell Transfer Therapy Segment by Application
2.4.1 Acute Lymphocytic Leukemia
2.4.2 NHL
2.4.3 Melanoma
2.4.4 Bladder Cancer
2.4.5 Lung Cancer
2.4.6 Head and Neck Cancer
2.4.7 Multiple Myeloma
2.4.8 Other
2.5 Adoptive Cell Transfer Therapy Market Size by Application
2.5.1 Global Adoptive Cell Transfer Therapy Market Size CAGR by Application
2.5.2 Global Adoptive Cell Transfer Therapy Market Size Market Share by Application (2016-2021)

3 Adoptive Cell Transfer Therapy Market Size by Players
3.1 Adoptive Cell Transfer Therapy Market Size Market Share by Players
3.1.1 Global Adoptive Cell Transfer Therapy Revenue by Players (2019-2021E)
3.1.2 Global Adoptive Cell Transfer Therapy Revenue Market Share by Players (2019-2021E)
3.2 Global Adoptive Cell Transfer Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Adoptive Cell Transfer Therapy by Regions
4.1 Adoptive Cell Transfer Therapy Market Size by Regions (2016-2021)
4.2 Americas Adoptive Cell Transfer Therapy Market Size Growth (2016-2021)
4.3 APAC Adoptive Cell Transfer Therapy Market Size Growth (2016-2021)
4.4 Europe Adoptive Cell Transfer Therapy Market Size Growth (2016-2021)
4.5 Middle East & Africa Adoptive Cell Transfer Therapy Market Size Growth (2016-2021)

5 Americas
5.1 Americas Adoptive Cell Transfer Therapy Market Size by Country (2016-2021)
5.2 Americas Adoptive Cell Transfer Therapy Market Size by Type (2016-2021)
5.3 Americas Adoptive Cell Transfer Therapy Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Adoptive Cell Transfer Therapy Market Size by Region (2016-2021)
6.2 APAC Adoptive Cell Transfer Therapy Market Size by Type (2016-2021)
6.3 APAC Adoptive Cell Transfer Therapy Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Adoptive Cell Transfer Therapy by Country (2016-2021)
7.2 Europe Adoptive Cell Transfer Therapy Market Size by Type (2016-2021)
7.3 Europe Adoptive Cell Transfer Therapy Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Adoptive Cell Transfer Therapy by Region (2016-2021)
8.2 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Type (2016-2021)
8.3 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Adoptive Cell Transfer Therapy Market Forecast
10.1 Global Adoptive Cell Transfer Therapy Forecast by Regions (2021-2026)
10.1.1 Global Adoptive Cell Transfer Therapy Forecast by Regions (2021-2026)
10.1.2 Americas Adoptive Cell Transfer Therapy Forecast
10.1.3 APAC Adoptive Cell Transfer Therapy Forecast
10.1.4 Europe Adoptive Cell Transfer Therapy Forecast
10.1.5 Middle East & Africa Adoptive Cell Transfer Therapy Forecast
10.2 Americas Adoptive Cell Transfer Therapy Forecast by Countries (2021-2026)
10.2.1 United States Adoptive Cell Transfer Therapy Market Forecast
10.2.2 Canada Adoptive Cell Transfer Therapy Market Forecast
10.2.3 Mexico Adoptive Cell Transfer Therapy Market Forecast
10.2.4 Brazil Adoptive Cell Transfer Therapy Market Forecast
10.3 APAC Adoptive Cell Transfer Therapy Forecast by Region (2021-2026)
10.3.1 China Adoptive Cell Transfer Therapy Market Forecast
10.3.2 Japan Adoptive Cell Transfer Therapy Market Forecast
10.3.3 Korea Adoptive Cell Transfer Therapy Market Forecast
10.3.4 Southeast Asia Adoptive Cell Transfer Therapy Market Forecast
10.3.5 India Adoptive Cell Transfer Therapy Market Forecast
10.3.6 Australia Adoptive Cell Transfer Therapy Market Forecast
10.4 Europe Adoptive Cell Transfer Therapy Forecast by Country (2021-2026)
10.4.1 Germany Adoptive Cell Transfer Therapy Market Forecast
10.4.2 France Adoptive Cell Transfer Therapy Market Forecast
10.4.3 UK Adoptive Cell Transfer Therapy Market Forecast
10.4.4 Italy Adoptive Cell Transfer Therapy Market Forecast
10.4.5 Russia Adoptive Cell Transfer Therapy Market Forecast
10.5 Middle East & Africa Adoptive Cell Transfer Therapy Forecast by Region (2021-2026)
10.5.1 Egypt Adoptive Cell Transfer Therapy Market Forecast
10.5.2 South Africa Adoptive Cell Transfer Therapy Market Forecast
10.5.3 Israel Adoptive Cell Transfer Therapy Market Forecast
10.5.4 Turkey Adoptive Cell Transfer Therapy Market Forecast
10.5.5 GCC Countries Adoptive Cell Transfer Therapy Market Forecast
10.6 Global Adoptive Cell Transfer Therapy Forecast by Type (2021-2026)
10.8 Global Adoptive Cell Transfer Therapy Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Novartis AG
11.1.1 Novartis AG Company Information
11.1.2 Novartis AG Adoptive Cell Transfer Therapy Product Offered
11.1.3 Novartis AG Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Novartis AG Main Business Overview
11.1.5 Novartis AG Latest Developments
11.2 Kite Pharma
11.2.1 Kite Pharma Company Information
11.2.2 Kite Pharma Adoptive Cell Transfer Therapy Product Offered
11.2.3 Kite Pharma Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Kite Pharma Main Business Overview
11.2.5 Kite Pharma Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Adoptive Cell Transfer Therapy Product Offered
11.3.3 Pfizer Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Juno Therapeutics
11.4.1 Juno Therapeutics Company Information
11.4.2 Juno Therapeutics Adoptive Cell Transfer Therapy Product Offered
11.4.3 Juno Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Juno Therapeutics Main Business Overview
11.4.5 Juno Therapeutics Latest Developments
11.5 Celgene Corporation
11.5.1 Celgene Corporation Company Information
11.5.2 Celgene Corporation Adoptive Cell Transfer Therapy Product Offered
11.5.3 Celgene Corporation Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Celgene Corporation Main Business Overview
11.5.5 Celgene Corporation Latest Developments
11.6 CARsgen Therapeutics
11.6.1 CARsgen Therapeutics Company Information
11.6.2 CARsgen Therapeutics Adoptive Cell Transfer Therapy Product Offered
11.6.3 CARsgen Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 CARsgen Therapeutics Main Business Overview
11.6.5 CARsgen Therapeutics Latest Developments
11.7 Sorrento Therapeutics
11.7.1 Sorrento Therapeutics Company Information
11.7.2 Sorrento Therapeutics Adoptive Cell Transfer Therapy Product Offered
11.7.3 Sorrento Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Sorrento Therapeutics Main Business Overview
11.7.5 Sorrento Therapeutics Latest Developments
11.8 Legend Biotech
11.8.1 Legend Biotech Company Information
11.8.2 Legend Biotech Adoptive Cell Transfer Therapy Product Offered
11.8.3 Legend Biotech Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Legend Biotech Main Business Overview
11.8.5 Legend Biotech Latest Developments
11.9 Atara Biotherapeutics
11.9.1 Atara Biotherapeutics Company Information
11.9.2 Atara Biotherapeutics Adoptive Cell Transfer Therapy Product Offered
11.9.3 Atara Biotherapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Atara Biotherapeutics Main Business Overview
11.9.5 Atara Biotherapeutics Latest Developments
11.10 Aurora Biopharma
11.10.1 Aurora Biopharma Company Information
11.10.2 Aurora Biopharma Adoptive Cell Transfer Therapy Product Offered
11.10.3 Aurora Biopharma Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Aurora Biopharma Main Business Overview
11.10.5 Aurora Biopharma Latest Developments
11. Autolus Therapeutics PLC
11.11.1 Autolus Therapeutics PLC Company Information
11.11.2 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Product Offered
11.11.3 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Autolus Therapeutics PLC Main Business Overview
11.11.5 Autolus Therapeutics PLC Latest Developments
11.12 Bluebird
11.12.1 Bluebird Company Information
11.12.2 Bluebird Adoptive Cell Transfer Therapy Product Offered
11.12.3 Bluebird Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Bluebird Main Business Overview
11.12.5 Bluebird Latest Developments
11.13 Carina Biotech
11.13.1 Carina Biotech Company Information
11.13.2 Carina Biotech Adoptive Cell Transfer Therapy Product Offered
11.13.3 Carina Biotech Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Carina Biotech Main Business Overview
11.13.5 Carina Biotech Latest Developments
11.14 Athenex
11.14.1 Athenex Company Information
11.14.2 Athenex Adoptive Cell Transfer Therapy Product Offered
11.14.3 Athenex Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Athenex Main Business Overview
11.14.5 Athenex Latest Developments
11.15 Xiangxue Pharmaceutical (Xiangxue Precision)
11.15.1 Xiangxue Pharmaceutical (Xiangxue Precision) Company Information
11.15.2 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Product Offered
11.15.3 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 Xiangxue Pharmaceutical (Xiangxue Precision) Main Business Overview
11.15.5 Xiangxue Pharmaceutical (Xiangxue Precision) Latest Developments
11.16 Hengrui Yuanzheng
11.16.1 Hengrui Yuanzheng Company Information
11.16.2 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Product Offered
11.16.3 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.16.4 Hengrui Yuanzheng Main Business Overview
11.16.5 Hengrui Yuanzheng Latest Developments
11.17 Eureka Therapeutics
11.17.1 Eureka Therapeutics Company Information
11.17.2 Eureka Therapeutics Adoptive Cell Transfer Therapy Product Offered
11.17.3 Eureka Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.17.4 Eureka Therapeutics Main Business Overview
11.17.5 Eureka Therapeutics Latest Developments
11.18 WuXi Juno
11.18.1 WuXi Juno Company Information
11.18.2 WuXi Juno Adoptive Cell Transfer Therapy Product Offered
11.18.3 WuXi Juno Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.18.4 WuXi Juno Main Business Overview
11.18.5 WuXi Juno Latest Developments
11.19 Shenzhen Inno Immunity
11.19.1 Shenzhen Inno Immunity Company Information
11.19.2 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Product Offered
11.19.3 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.19.4 Shenzhen Inno Immunity Main Business Overview
11.19.5 Shenzhen Inno Immunity Latest Developments
11.20 Shenzhen Binde Bio
11.20.1 Shenzhen Binde Bio Company Information
11.20.2 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Product Offered
11.20.3 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.20.4 Shenzhen Binde Bio Main Business Overview
11.20.5 Shenzhen Binde Bio Latest Developments
11.21 Kerui Bio
11.21.1 Kerui Bio Company Information
11.21.2 Kerui Bio Adoptive Cell Transfer Therapy Product Offered
11.21.3 Kerui Bio Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.21.4 Kerui Bio Main Business Overview
11.21.5 Kerui Bio Latest Developments
11.22 Adaptimmune
11.22.1 Adaptimmune Company Information
11.22.2 Adaptimmune Adoptive Cell Transfer Therapy Product Offered
11.22.3 Adaptimmune Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.22.4 Adaptimmune Main Business Overview
11.22.5 Adaptimmune Latest Developments
11.23 Altor Bioscience Corporation
11.23.1 Altor Bioscience Corporation Company Information
11.23.2 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Product Offered
11.23.3 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.23.4 Altor Bioscience Corporation Main Business Overview
11.23.5 Altor Bioscience Corporation Latest Developments
11.24 Cellectis
11.24.1 Cellectis Company Information
11.24.2 Cellectis Adoptive Cell Transfer Therapy Product Offered
11.24.3 Cellectis Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.24.4 Cellectis Main Business Overview
11.24.5 Cellectis Latest Developments
11.25 Takara Bio
11.25.1 Takara Bio Company Information
11.25.2 Takara Bio Adoptive Cell Transfer Therapy Product Offered
11.25.3 Takara Bio Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.25.4 Takara Bio Main Business Overview
11.25.5 Takara Bio Latest Developments
11.26 Unum Therapeutics
11.26.1 Unum Therapeutics Company Information
11.26.2 Unum Therapeutics Adoptive Cell Transfer Therapy Product Offered
11.26.3 Unum Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.26.4 Unum Therapeutics Main Business Overview
11.26.5 Unum Therapeutics Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Adoptive Cell Transfer Therapy Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of NK
Table 3. Major Players of LAK
Table 4. Major Players of DC
Table 5. Major Players of CIK
Table 6. Major Players of CTL
Table 7. Major Players of TIL
Table 8. Major Players of TCR-T
Table 9. Major Players of CAR-T
Table 10. Adoptive Cell Transfer Therapy Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 11. Global Adoptive Cell Transfer Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 12. Global Adoptive Cell Transfer Therapy Market Size Market Share by Type (2016-2021)
Table 13. Adoptive Cell Transfer Therapy Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 14. Global Adoptive Cell Transfer Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 15. Global Adoptive Cell Transfer Therapy Market Size Market Share by Application (2016-2021)
Table 16. Global Adoptive Cell Transfer Therapy Revenue by Players (2019-2021E) & ($ Millions)
Table 17. Global Adoptive Cell Transfer Therapy Revenue Market Share by Players (2019-2021E)
Table 18. Adoptive Cell Transfer Therapy Key Players Head office and Products Offered
Table 19. Adoptive Cell Transfer Therapy Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Adoptive Cell Transfer Therapy Market Size by Regions 2016-2021 & ($ Millions)
Table 23. Global Adoptive Cell Transfer Therapy Market Size Market Share by Regions 2016-2021
Table 24. Americas Adoptive Cell Transfer Therapy Market Size by Country (2016-2021) & ($ Millions)
Table 25. Americas Adoptive Cell Transfer Therapy Market Size Market Share by Country (2016-2021)
Table 26. Americas Adoptive Cell Transfer Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 27. Americas Adoptive Cell Transfer Therapy Market Size Market Share by Type (2016-2021)
Table 28. Americas Adoptive Cell Transfer Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 29. Americas Adoptive Cell Transfer Therapy Market Size Market Share by Application (2016-2021)
Table 30. APAC Adoptive Cell Transfer Therapy Market Size by Region (2016-2021) & ($ Millions)
Table 31. APAC Adoptive Cell Transfer Therapy Market Size Market Share by Region (2016-2021)
Table 32. APAC Adoptive Cell Transfer Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 33. APAC Adoptive Cell Transfer Therapy Market Size Market Share by Type (2016-2021)
Table 34. APAC Adoptive Cell Transfer Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 35. APAC Adoptive Cell Transfer Therapy Market Size Market Share by Application (2016-2021)
Table 36. Europe Adoptive Cell Transfer Therapy Market Size by Country (2016-2021) & ($ Millions)
Table 37. Europe Adoptive Cell Transfer Therapy Market Size Market Share by Country (2016-2021)
Table 38. Europe Adoptive Cell Transfer Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 39. Europe Adoptive Cell Transfer Therapy Market Size Market Share by Type (2016-2021)
Table 40. Europe Adoptive Cell Transfer Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 41. Europe Adoptive Cell Transfer Therapy Market Size Market Share by Application (2016-2021)
Table 42. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Region (2016-2021) & ($ Millions)
Table 43. Middle East & Africa Adoptive Cell Transfer Therapy Market Size Market Share by Region (2016-2021)
Table 44. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 45. Middle East & Africa Adoptive Cell Transfer Therapy Market Size Market Share by Type (2016-2021)
Table 46. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 47. Middle East & Africa Adoptive Cell Transfer Therapy Market Size Market Share by Application (2016-2021)
Table 48. Key and Potential Regions of Adoptive Cell Transfer Therapy
Table 49. Key Application and Potential Industries of Adoptive Cell Transfer Therapy
Table 50. Key Challenges of Adoptive Cell Transfer Therapy
Table 51. Key Trends of Adoptive Cell Transfer Therapy
Table 52. Global Adoptive Cell Transfer Therapy Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 53. Global Adoptive Cell Transfer Therapy Market Size Market Share Forecast by Regions (2021-2026)
Table 54. Global Adoptive Cell Transfer Therapy Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 55. Global Adoptive Cell Transfer Therapy Market Size Market Share Forecast by Type (2021-2026)
Table 56. Global Adoptive Cell Transfer Therapy Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 57. Global Adoptive Cell Transfer Therapy Market Size Market Share Forecast by Application (2021-2026)
Table 58. Novartis AG Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 59. Novartis AG Adoptive Cell Transfer Therapy Product Offered
Table 60. Novartis AG Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 61. Novartis AG Main Business
Table 62. Novartis AG Latest Developments
Table 63. Kite Pharma Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 64. Kite Pharma Adoptive Cell Transfer Therapy Product Offered
Table 65. Kite Pharma Main Business
Table 66. Kite Pharma Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 67. Kite Pharma Latest Developments
Table 68. Pfizer Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 69. Pfizer Adoptive Cell Transfer Therapy Product Offered
Table 70. Pfizer Main Business
Table 71. Pfizer Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 72. Pfizer Latest Developments
Table 73. Juno Therapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 74. Juno Therapeutics Adoptive Cell Transfer Therapy Product Offered
Table 75. Juno Therapeutics Main Business
Table 76. Juno Therapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 77. Juno Therapeutics Latest Developments
Table 78. Celgene Corporation Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 79. Celgene Corporation Adoptive Cell Transfer Therapy Product Offered
Table 80. Celgene Corporation Main Business
Table 81. Celgene Corporation Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 82. Celgene Corporation Latest Developments
Table 83. CARsgen Therapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 84. CARsgen Therapeutics Adoptive Cell Transfer Therapy Product Offered
Table 85. CARsgen Therapeutics Main Business
Table 86. CARsgen Therapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 87. CARsgen Therapeutics Latest Developments
Table 88. Sorrento Therapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 89. Sorrento Therapeutics Adoptive Cell Transfer Therapy Product Offered
Table 90. Sorrento Therapeutics Main Business
Table 91. Sorrento Therapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 92. Sorrento Therapeutics Latest Developments
Table 93. Legend Biotech Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 94. Legend Biotech Adoptive Cell Transfer Therapy Product Offered
Table 95. Legend Biotech Main Business
Table 96. Legend Biotech Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 97. Legend Biotech Latest Developments
Table 98. Atara Biotherapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 99. Atara Biotherapeutics Adoptive Cell Transfer Therapy Product Offered
Table 100. Atara Biotherapeutics Main Business
Table 101. Atara Biotherapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 102. Atara Biotherapeutics Latest Developments
Table 103. Aurora Biopharma Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 104. Aurora Biopharma Adoptive Cell Transfer Therapy Product Offered
Table 105. Aurora Biopharma Main Business
Table 106. Aurora Biopharma Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 107. Aurora Biopharma Latest Developments
Table 108. Autolus Therapeutics PLC Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 109. Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Product Offered
Table 110. Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 111. Autolus Therapeutics PLC Main Business
Table 112. Autolus Therapeutics PLC Latest Developments
Table 113. Bluebird Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 114. Bluebird Adoptive Cell Transfer Therapy Product Offered
Table 115. Bluebird Main Business
Table 116. Bluebird Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 117. Bluebird Latest Developments
Table 118. Carina Biotech Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 119. Carina Biotech Adoptive Cell Transfer Therapy Product Offered
Table 120. Carina Biotech Main Business
Table 121. Carina Biotech Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 122. Carina Biotech Latest Developments
Table 123. Athenex Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 124. Athenex Adoptive Cell Transfer Therapy Product Offered
Table 125. Athenex Main Business
Table 126. Athenex Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 127. Athenex Latest Developments
Table 128. Xiangxue Pharmaceutical (Xiangxue Precision) Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 129. Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Product Offered
Table 130. Xiangxue Pharmaceutical (Xiangxue Precision) Main Business
Table 131. Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 132. Xiangxue Pharmaceutical (Xiangxue Precision) Latest Developments
Table 133. Hengrui Yuanzheng Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 134. Hengrui Yuanzheng Adoptive Cell Transfer Therapy Product Offered
Table 135. Hengrui Yuanzheng Main Business
Table 136. Hengrui Yuanzheng Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 137. Hengrui Yuanzheng Latest Developments
Table 138. Eureka Therapeutics Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 139. Eureka Therapeutics Adoptive Cell Transfer Therapy Product Offered
Table 140. Eureka Therapeutics Main Business
Table 141. Eureka Therapeutics Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 142. Eureka Therapeutics Latest Developments
Table 143. WuXi Juno Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 144. WuXi Juno Adoptive Cell Transfer Therapy Product Offered
Table 145. WuXi Juno Main Business
Table 146. WuXi Juno Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 147. WuXi Juno Latest Developments
Table 148. Shenzhen Inno Immunity Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 149. Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Product Offered
Table 150. Shenzhen Inno Immunity Main Business
Table 151. Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 152. Shenzhen Inno Immunity Latest Developments
Table 153. Shenzhen Binde Bio Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 154. Shenzhen Binde Bio Adoptive Cell Transfer Therapy Product Offered
Table 155. Shenzhen Binde Bio Main Business
Table 156. Shenzhen Binde Bio Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 157. Shenzhen Binde Bio Latest Developments
Table 158. Kerui Bio Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 159. Kerui Bio Adoptive Cell Transfer Therapy Product Offered
Table 160. Kerui Bio Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 161. Kerui Bio Main Business
Table 162. Kerui Bio Latest Developments
Table 163. Adaptimmune Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 164. Adaptimmune Adoptive Cell Transfer Therapy Product Offered
Table 165. Adaptimmune Main Business
Table 166. Adaptimmune Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 167. Adaptimmune Latest Developments
Table 168. Altor Bioscience Corporation Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 169. Altor Bioscience Corporation Adoptive Cell Transfer Therapy Product Offered
Table 170. Altor Bioscience Corporation Main Business
Table 171. Altor Bioscience Corporation Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 172. Altor Bioscience Corporation Latest Developments
Table 173. Cellectis Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 174. Cellectis Adoptive Cell Transfer Therapy Product Offered
Table 175. Cellectis Main Business
Table 176. Cellectis Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 177. Cellectis Latest Developments
Table 178. Takara Bio Details, Company Type, Adoptive Cell Transfer Therapy Area Served and Its Competitors
Table 179. Takara Bio Adoptive Cell Transfer Therapy Product Offered
Table 180. Takara Bio Main Business
Table 181. Takara Bio Adoptive Cell Transfer Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 182. Takara Bio Latest Developments
Table 183. Unum Therapeutics Details, Company Type, Adoptive Ce

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs